KrASIA:XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2BThe company provides its AI technology to pharmaceutical companies to enhance R&D for new drugs.AI pharmaceutical company XtalPi secured USD 400 million
Click here to read full news..
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.